within Pharmacolibrary.Drugs.ATC.N;

model N06AA10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.441,
    Cl             = 0.00038166666666666666,
    adminDuration  = 600,
    adminMass      = 75 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0159,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.003916666666666666,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N06AA10</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Nortriptyline is a tricyclic antidepressant primarily used in the treatment of major depressive disorder and sometimes for chronic neuropathic pain. It is an active metabolite of amitriptyline and is approved in many countries, including the US and UK, for clinical use, though newer antidepressants are often preferred due to a better side effect profile.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Norkus, C, et al., &amp; KuKanich, B (2015). Pharmacokinetics of intravenous and oral amitriptyline and its active metabolite nortriptyline in Greyhound dogs. <i>Veterinary anaesthesia and analgesia</i> 42(6) 580–589. DOI:<a href=&quot;https://doi.org/10.1111/vaa.12248&quot;>10.1111/vaa.12248</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25683584/&quot;>https://pubmed.ncbi.nlm.nih.gov/25683584</a></p></li><li><p>Dawling, S, et al., &amp; Braithwaite, R (1980). Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers. <i>Clinical pharmacokinetics</i> 5(4) 394–401. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198005040-00007&quot;>10.2165/00003088-198005040-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6994983/&quot;>https://pubmed.ncbi.nlm.nih.gov/6994983</a></p></li><li><p>Norkus, C, et al., &amp; KuKanich, B (2015). Evaluation of the pharmacokinetics of oral amitriptyline and its active metabolite nortriptyline in fed and fasted Greyhound dogs. <i>Journal of veterinary pharmacology and therapeutics</i> 38(6) 619–622. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12237&quot;>10.1111/jvp.12237</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25989225/&quot;>https://pubmed.ncbi.nlm.nih.gov/25989225</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N06AA10;
